Mentor Capital, Inc. and CI Companies

$10M Cancer Assets
3M Basic Shares

 Trading Chart

 

The Mentor Capital Cancer Immunotherapy Index ©

PDF Document Click to see larger

Cancer Immunotherapy Index

* Cancer Immunotherapy Index was developed with Mike Havrilla, PhD., Editor of MikeHavRx.com, initially as a sub-set to his Cancer Diagnostic & Therapeutic Micro-Cap Index.
** 75% historic gain on Quantum Immunologics included in total which increases reported gain by 0.0005%. Private companies such as QI removed from index 2/12/2011.
*** Market Data from National Cancer Institute based on Relative Mortality in company treatment areas with market shared by all participating companies in their treatment areas.

NO INVESTMENT ADVISORY DISCLAIMER: Readers are cautioned that Mentor Capital, Inc. does not intend this Cancer Immunotherapy Index to be investment advice. The CI Index is a mathematical, information only index and has been published on a regular weekly basis since inception. The original and continuing purpose is to establish a benchmark as to how the cancer immunotherapy sector as a whole has behaved. As such, it presents historic information and does not purport nor imply any opinion or advice on the current or future value of any stock, nor account for trading costs that in practice will reduce investment gains.